Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Researchers running the Com-Cov study, launched in February to investigate alternating doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine, have today announced that the programme will be extended to include the Moderna and Novavax vaccines in a new study.

Syringe and vaccine vial

What is unhealthy about public health? Vaccination, evidence and the politics of uncertainty

Journal article

Mezza M. and Vanderslott S., (2026), Humanities and Social Sciences Communications, 13

Accurately modeling RNase H-mediated antisense oligonucleotide efficacy

Journal article

Hill B. et al, (2026), Molecular Therapy Nucleic Acids, 37

ChAdOx1 nCoV-19 coronavirus vaccine: Long-term safety and immunological responses.

Journal article

Ebrahimi N. et al, (2026), Vaccine, 88

Conference report: airway mucosal sampling and immune analysis.

Journal article

Rosenheim J. et al, (2026), Vaccine, 88

Emerging Therapies for Angelman Syndrome.

Journal article

Tychon C. et al, (2026), CNS Drugs

Load More